These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18314617)

  • 1. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
    Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
    Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
    Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
    J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.
    Ai L; Kim WJ; Kim TY; Fields CR; Massoll NA; Robertson KD; Brown KD
    Cancer Res; 2006 Aug; 66(16):7899-909. PubMed ID: 16912163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue.
    Kwon MS; Kim SJ; Lee SY; Jeong JH; Lee ES; Kang HS
    Oncol Rep; 2006 Jan; 15(1):27-32. PubMed ID: 16328031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
    Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
    Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
    Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
    Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
    Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
    Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
    Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
    Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
    Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
    Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA expression profile in undifferentiated gastric cancer.
    Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
    Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer.
    Li X; Cowell JK; Sossey-Alaoui K
    Oncogene; 2004 Feb; 23(7):1474-80. PubMed ID: 14973555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
    Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
    Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
    Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
    Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.